Prothena Corporation plc - Ordinary Shares (PRTA) Social Stream



Prothena Corporation plc - Ordinary Shares (PRTA): $26.81

0.04 (+0.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PRTA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 397

in industry

Prothena Corp Public Ltd Co (PRTA) Price Targets From Analysts

Use the tables below to see what analysts covering Prothena Corp Public Ltd Co think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 8 $103 $29 $76.5 $39.06 95.85%
2022-01-13 9 $103 $29 $76.555 $39.06 95.99%
2022-01-20 9 $100 $29 $73.555 $39.06 88.31%
2022-01-26 9 $100 $29 $71.111 $39.06 82.06%
2022-02-02 7 $100 $54 $76.375 $39.06 95.53%
2022-02-17 8 $100 $54 $76.375 $39.06 95.53%
2022-02-18 7 $100 $52 $76.125 $39.06 94.89%
2022-03-22 7 $100 $47 $75.5 $39.06 93.29%

The Trend in the Analyst Price Target


PRTA's average price target has moved down $1 over the prior 137 days.

Over the past 137 days, PRTA's average upside potential has been 93.91%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-13 9 103 29 76.555 37.24 105.57%
2022-01-20 9 100 29 73.555 35.43 107.61%
2022-01-26 9 100 54 76.375 33.73 126.43%
2022-02-02 7 100 54 76.375 32.73 133.35%
2022-02-02 8 100 54 76.375 32.73 133.35%

PRTA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.29 6 0 1 0 0 7

The Trend in the Broker Recommendations


Over the past 19 months, PRTA's average broker recommendation rating improved by 0.88.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Prothena Corp Public Ltd Co's variance in analysts' estimates is lower than -819.75% of them.
  • Prothena Corp Public Ltd Co's upside potential (average analyst target price relative to current price) is higher than 837.91% of all US stocks.
  • In terms of how Prothena Corp Public Ltd Co fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 893.97% of that group.
  • In the context of Pharmaceutical Products stocks, Prothena Corp Public Ltd Co's number of analysts covering the stock is greater than 769.37% of them.

In the Pharmaceutical Products industry, PRLD, PRAX, and PMVP are the three stocks most similar to Prothena Corp Public Ltd Co regarding the price target and analyst recommendation information presented here.

Is PRTA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4142 seconds.